ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Niederhuber Chairman of NCAB

August 2, 2002

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Abigail Alliance says statisticians usurped control of oncology. Milken’s optimism fuels the movement.

August 5, 2005

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

Physician Bonus Denied Some Agencies; NIH Status Unsure

January 18, 1991

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981